Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175. Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518. In the Literature Feb 2005 Thoughts on Koch's Postulates Peter A. Ubel, MD Virtual Mentor. 2005;7(2):168-170. doi: 10.1001/virtualmentor.2005.7.2.jdsc4-0502. In the Literature Aug 2009 The Belmont Report's Misleading Conception of Autonomy Sigurdur Kristinsson, PhD Virtual Mentor. 2009;611-616. doi: 10.1001/virtualmentor.2009.11.8.jdsc1-0908. In the Literature Nov 2005 In the Left Corner: The Starving Endocrinologist Christina Fradelos Virtual Mentor. 2005;7(11):748-750. doi: 10.1001/virtualmentor.2005.7.11.jdsc1-0511. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. In the Literature Feb 2011 Improving Institutional Review of Community-Based Participatory Research Applications Andrew Plunk, MPH By privileging traditional research methods in forms for research protocol approval, IRBs can unknowingly allow community partners to be harmed in CBPR. Changes to the language can help ensure appropriate sensitivity and community involvement. Virtual Mentor. 2011;13(2):102-104. doi: 10.1001/virtualmentor.2011.13.2.jdsc1-1102. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.
Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518.
In the Literature Feb 2005 Thoughts on Koch's Postulates Peter A. Ubel, MD Virtual Mentor. 2005;7(2):168-170. doi: 10.1001/virtualmentor.2005.7.2.jdsc4-0502.
In the Literature Aug 2009 The Belmont Report's Misleading Conception of Autonomy Sigurdur Kristinsson, PhD Virtual Mentor. 2009;611-616. doi: 10.1001/virtualmentor.2009.11.8.jdsc1-0908.
In the Literature Nov 2005 In the Left Corner: The Starving Endocrinologist Christina Fradelos Virtual Mentor. 2005;7(11):748-750. doi: 10.1001/virtualmentor.2005.7.11.jdsc1-0511.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
In the Literature Feb 2011 Improving Institutional Review of Community-Based Participatory Research Applications Andrew Plunk, MPH By privileging traditional research methods in forms for research protocol approval, IRBs can unknowingly allow community partners to be harmed in CBPR. Changes to the language can help ensure appropriate sensitivity and community involvement. Virtual Mentor. 2011;13(2):102-104. doi: 10.1001/virtualmentor.2011.13.2.jdsc1-1102.